Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
A rainy morning in the nation's medicine chest. Clouds, however, will not deter us from maintaining an optimistic outlook. Already, there is much to keep one excited. Here are a few examples...
Throwing Out Old Meds? Don't Flush. Mix Them With Cat Litter (Associated Press)
Merck And GTx Strike Deal For Age-Related Muscle Loss (Yahoo/Reuters)
Bayer Posts Higher Profits Due To Drugs, Cuts Plastics Jobs (Bloomberg News)
Schering-Plough Has No Liability In AWP Federal Case (CNNMoney/Dow Jones)
